Multi Garam Utama Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Multi Garam Utama Tbk. trades at Rp262 (market cap 1.03T, 49.73M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Multi Garam Utama Tbk. is far larger — about 9.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| FOLK | SCPI | |
|---|---|---|
Market Cap | 1.03T | 104.4B |
Volume | 49.73M | — |
Lot | 497.29K | — |
Turnover | 12.45B | — |
Average Price | 250.32 | — |
Value | 12.45B | — |
Indicative Equilibrium Price | 262 | — |
Indicative Equilibrium Volume | 8.45K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Multi Garam Utama Tbk (the ”Company”) was established based on Notarial Deed No. 6 of Tri Theresa Tarigan, S.H., M.Kn., dated April 10, 2019.
Read more on FOLK →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →